Abstract | BACKGROUND: Axillary hyperhidrosis causes considerable emotional stress and is associated with extraordinary costs and limitations in clothing. Existing topical and surgical therapies are either ineffective or associated with unacceptable morbidity and sequelae. Botulinum A neurotoxin ( Botox) has been shown to decrease sweating in normal skin and in palmar hyperhidrosis. OBJECTIVE: The current study was undertaken to demonstrate the utility of using Botox in the treatment of axillary hyperhidrosis. METHODS: RESULTS: All patients enjoyed relatively complete anhidrosis of the axillary skin in periods ranging from 4 to 7 months. Repeat injections produced similar results. CONCLUSION:
|
Authors | R G Glogau |
Journal | Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
(Dermatol Surg)
Vol. 24
Issue 8
Pg. 817-9
(Aug 1998)
ISSN: 1076-0512 [Print] United States |
PMID | 9723044
(Publication Type: Journal Article)
|
Chemical References |
- Neuromuscular Agents
- Botulinum Toxins, Type A
|
Topics |
- Adult
- Axilla
- Botulinum Toxins, Type A
(administration & dosage, therapeutic use)
- Female
- Follow-Up Studies
- Humans
- Hyperhidrosis
(psychology, therapy)
- Injections, Intradermal
- Male
- Middle Aged
- Neuromuscular Agents
(administration & dosage, therapeutic use)
- Retreatment
- Stress, Psychological
(physiopathology)
- Sweating
(physiology)
|